Physician

Mark J Ross, M.D.

According to 2025 Medicare claims, Mark Ross, M.D. (NPI: 1508869090) practices ophthalmology in the Florence, SC market, with the plurality of this provider's patient population coming from Florence, SC. This provider's primary affiliated billing organization is STOKES REGIONAL EYE CENTERS (NPI: 1194713636; TIN: 570523600) and primary practice location at 29501-3429.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,893 traditional Medicare patients, billed 4,263 HCPCS/CPT codes, and received $355,493 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,527 prescription claims across 1,280 beneficiaries totaling $507,102 in drug costs, led by Lumigan (Bimatoprost). 2020 DME data shows 28 claims. Open Payments data shows 1 records totaling $22. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $615,750 to $355,493. In contrast, Part D prescription costs have risen steadily, from $442,192 to $507,102. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,421	6,152	$615,750
2016	2,330	6,698	$607,659
2017	2,422	6,581	$498,844
2018	2,232	5,475	$416,058
2019	2,134	5,339	$465,670
2020	2,136	4,942	$404,796
2021	2,306	5,531	$436,366
2022	2,172	5,149	$402,539
2023	1,970	4,621	$358,923
2024	1,893	4,263	$355,493

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	924	5,141	$442,192
2016	868	5,223	$478,849
2017	956	5,442	$522,520
2018	977	5,580	$522,651
2019	991	5,251	$579,889
2020	1,123	5,292	$614,751
2021	1,266	6,432	$724,959
2022	1,300	6,925	$685,507
2023	1,320	6,608	$596,106
2024	1,280	6,527	$507,102

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	25	$1,118
2016	14	14	$811
2017	13	13	$659
2018	27	27	$1,813
2019	41	41	$2,480
2020	28	28	$1,826
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	733	742	$87
92014	Established patient complete exam of visual system	401	401	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	644	777	$60
92083	Exam of visual field with extended testing	318	322	$42
92133	Imaging of optic nerve	444	445	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	168	10,467	$96,574
Restasis	Cyclosporine	56	3,450	$70,433
Rhopressa	Netarsudil Mesylate	124	5,456	$59,547
Alphagan P	Brimonidine Tartrate	81	3,671	$29,153
Prednisolone Acetate	Prednisolone Acetate	679	19,882	$24,366

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$22	Thea Pharma Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark J. Ross, M.D.?

Tedicare shows public-source Medicare data for Mark J. Ross, M.D. (NPI 1508869090), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark J. Ross, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark J. Ross, M.D.?

Mark J. Ross, M.D. is linked to STOKES REGIONAL EYE CENTERS (billing NPI 1194713636) in the available physician profile data.

Does Mark J. Ross, M.D. have Open Payments data?

Mark J. Ross, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.